Fused heterocyclic compounds as S1P modulators

US10556907B2 · kind B2 · utility

Assignees

• Abb Vie Deutschland Gmbh & Co. KG · DE
• Abb Vie Inc. · US

Inventors

• Udo Lange · Ludwigshafen, DE
• Michael Ochse · Wiesbaden, DE
• Elizabeth Louise VAN DER KAM · Weesp, NL
• Jeroen VAN BERGEIJK · Ludwigshafen, DE
• Sean Colm Turner · Ludwigshafen, DE
• Frank Oellien · Ludwigshafen, DE
• Patrick Walleser · Ludwigshafen, DE
• Wilhelm Amberg · Ludwigshafen, DE
• Wilfried Hornberger · Wiesbaden, DE
• Hervé Geneste · Schifferstadt, DE
• Mario Mezler · Ludwigshafen, DE
• Charles W. Hutchins · Libertyville, US

Key dates

• Filing date: Aug 26, 2016
• Grant date: Feb 11, 2020
• Expiry date: Aug 26, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to heterocyclic compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.